DAPAGLIFLOZIN (Forxiga®)

Clinical Indication

Chronic Heart failure with reduced ejection fraction and preserved ejection fraction

Comments

In line with NICE TA679 and  NICE TA902

Date of classification

March 2021

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .